Related Experiment Videos
Serial lung function and elastic recoil 2 years after lung volume reduction surgery for emphysema
A F Gelb1, M Brenner, R J McKenna
1Department of Medicine, Lakewood Regional Medical Center, University of California, Los Angeles, School of Medicine, USA.
Chest
|June 19, 1998
Summary
Lung volume reduction surgery improves breathing in severe emphysema patients. Increased lung elastic recoil is the main reason for better airflow limitation two years after the procedure.
Area of Science:
- Pulmonary Medicine
- Thoracic Surgery
- Respiratory Physiology
Background:
- Severe emphysema significantly impairs lung function and quality of life.
- Lung volume reduction surgery (LVRS) is a therapeutic option for select patients with severe emphysema.
Purpose of the Study:
- To evaluate serial lung function, including elastic recoil, after bilateral LVRS in severe emphysema patients.
- To identify the mechanisms responsible for improved airflow limitation post-LVRS.
Main Methods:
- 12 patients with severe emphysema underwent thoracoscopic bilateral LVRS.
- Lung function was assessed 6 months to 2 years post-surgery, with pre-operative baseline measurements.
- Key parameters included total lung capacity (TLC), functional residual capacity (FRC), residual volume (RV), FEV1, diffusing capacity, static lung elastic recoil pressure (Pstat), and maximum oxygen consumption.
Main Results:
- Two years post-LVRS, 10 of 12 patients reported improved dyspnea relief, and 2 of 7 oxygen-dependent patients were weaned.
- Significant reductions in TLC, FRC, and RV were observed.
- Increases in FEV1, diffusing capacity, static lung elastic recoil pressure, and maximum oxygen consumption were significant.
- Improved FEV1 correlated with increased Pstat/TLC ratio.
Conclusions:
- Bilateral LVRS provides variable clinical and physiological benefits in severe emphysema patients up to two years post-surgery.
- Increased lung elastic recoil appears to be the primary mechanism driving the improvement in airflow limitation.
- Clinical improvements did not correlate with any specific baseline parameter.